Disparities in stage at diagnosis for liver cancer in China-Reference-Cited by-同舟云学术

Disparities in stage at diagnosis for liver cancer in China

Published:2023-03 Issue:1 Volume:3 Page:7-13
ISSN:2667-0054
Container-title:Journal of the National Cancer Center
language:en
Short-container-title:Journal of the National Cancer Center

Author:

Shan Tianhao^ORCID,Ran Xianhui,Li Huizhang,Feng Guoshuang,Zhang Siwei,Zhang Xuehong,Zhang Lei^ORCID,Lu Lingeng^ORCID,An Lan,Fu Ruiying,Sun Kexin,Wang Shaoming^ORCID,Chen Ru,Li Li,Chen Wanqing,Wei Wenqiang,Zeng Hongmei,He Jie^ORCID

Publisher

Elsevier BV

Subject

Oncology,Hematology,Cancer Research

Reference45 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cancer incidence and mortality in China, 2016;Zheng;J Natl Cancer Cent,2022

3. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries;Zeng;Lancet Glob Health,2018

4. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018

5. Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study;Ryzhov;Lancet Oncol,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleolar NOL9 regulated by DNA methylation promotes hepatocellular carcinoma growth by activating wnt/beta-catenin pathway;2024-08-19

2. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

3. Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study;Frontiers in Oncology;2024-07-05

4. Clinicopathological and therapeutic comparisons of esophageal cancer between China and the USA: a multicenter hospital-based study;Journal of the National Cancer Center;2024-04

5. Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma;Nature Reviews Clinical Oncology;2024-02-29